ALG14 p.Val6Ile
c.16G>A · rs756921157 · VCV1356542
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0736 | likely benign |
|---|---|---|
| SaProt | LLR -6.94 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -3.3 | GERP -3.4 |
| Regional constraint | o/e 1.06 | unconstrained · MANE · 90 kb · p 0.32 · regional, not allelic |
| Overall | ||
| CADD | 0.033 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0048% | 20,827 |
| European (non-Finnish)grpmax | 0.00237% | 42,143 |
| African / African-American | 0.00133% | 74,918 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ALG14
- Protein
- p.Val6Ile
- Coding
- c.16G>A
- MANE Select
- NM_144988
- dbSNP
- rs756921157
- Type
- single nucleotide variant
- Location
- chr1:95072883 (GRCh38)
- Gene constraint
- LOEUF 1.055 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 91.06
Disease context
intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: congenital myasthenic syndrome 15myopathy, epilepsy, and progressive cerebral atrophy
Similar variants
- ALG14 p.Ala13Ser Uncertain significance ★★ ⚠ same condition
- ALG14 p.Arg104Gln Uncertain significance ★★ ⚠ same condition
- ALG14 p.Arg109Gln Uncertain significance ★★ ⚠ same condition
- ALG14 p.Asn61Asp Uncertain significance ★★ ⚠ same condition
- ALG14 p.Asn61Ser Uncertain significance ★★ ⚠ same condition
- ALG14 p.Asn82Ser Uncertain significance ★★ ⚠ same condition
- ALG14 p.Glu110Lys Uncertain significance ★★ same condition
- ALG14 p.Glu179Lys Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/alg14-p-val6ile (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown